Interferon Alfa

Drug Levels and Effects:




Summary of Use during Lactation:


Because of the low levels in milk, poor oral absorption by the infant, it is unlikely that interferon use by a nursing mother presents any serious risk to the breastfed infant. Holder pasteurization (62.5 degrees C for 30 minutes) decreases the concentration of endogenous interferon-gamma by an average about 10%.[1]


Drug Levels:


Two mothers taking interferon alfa had milk levels measured. One mother taking 8 million units three times a week had a milk level of 1400 units/L and another taking 8 million units/day had a milk level of 6000 units/L. Both levels were apparently measured immediately postpartum (in colostrum), but the time since the previous dose was not stated.[2]

An intravenous dose of 30 million units of interferon alfa-2B in one woman resulted in a peak milk level of 1551 International Units/L which was a slight increase over two baseline levels prior to the dose which averaged 1072 International Units/L . By 12 hours after the dose, milk interferon levels were lower than baseline.[3]


Effects in Breastfed Infants:


One infant was born to a mother who received 3 million units of interferon alfa subcutaneously 3 times weekly during pregnancy and postpartum for essential thrombocytopenia. Her infant was breastfed for 2 weeks postpartum before bilateral mastitis caused the mother to terminate nursing. The infant reportedly thrived, although specific measures were not mentioned.[4]


Possible Effects on Lactation:


Relevant published information was not found as of the revision date.


Alternate Drugs to Consider:


Dependent on the condition being treated.


References:


1. Ewaschuk JB, Unger S, O'Connor DL et al. Effect of pasteurization on selected immune components of donatedhumanbreast milk. J Perinatol. 2011;31:593-8. PMID:21330996
2. Haggstrom J, Adriansson M, Hybbinette T et al. Two cases of CML treated withalpha-interferon during second and third trimester of pregnancy with analysis of the drug in the new-born immediately postpartum. Eur J Haematol. 1996;57:101-2. Letter. PMID:8698119
3. Kumar AR, Hale TW, Mock RE. Transfer of interferon alfa intohumanbreast milk. J Hum Lact. 2000;16:226-8. PMID:11153157
4. Williams JM, Schlesinger PE, Gray AG. Successful treatment of essential thrombocythaemia and recurrent abortion withalphainterferon. Br J Haematol. 1994;88:647-8. PMID:7819084



Substance Identification:




Substance Name:

Interferon Alfa

CAS Registry Number:

9008-11-1

Drug Class:


  • AntiInfective Agents

  • Antiviral Agents

  • Antineoplastic Agents


  • Administrative Information:




    LactMed Record Number:


    148


    Last Revision Date:


    Disclaimer:Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.